Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Internal medicine: guidance to the diagnosis and management of restless legs syndrome Ball E; Caivano CKSouth Med J 2008[Jun]; 101 (6): 631-4Restless legs syndrome (RLS) is a chronic neurologic disorder, with a prevalence rate in the general population of 5% to 10%. The diagnosis of RLS is straightforward; it is based on symptom history alone and uses the four essential diagnostic criteria for RLS. Owing to the heterogeneity of the disorder, the sensory and motor symptoms of RLS are often attributed to other disorders, and many patients remain undiagnosed and untreated. The symptoms of RLS are thought to result from a central dopaminergic dysfunction. Dopamine agonists are considered first-line treatment for moderate-to-severe primary RLS, although other nondopaminergic therapies are sometimes used to ease the symptoms of RLS. This article will guide primary care and internal medicine specialists through the diagnosis and management options of primary RLS.|*Critical Pathways[MESH]|Benzothiazoles/therapeutic use[MESH]|Cross-Sectional Studies[MESH]|Dopamine Agonists/therapeutic use[MESH]|Humans[MESH]|Indoles/therapeutic use[MESH]|Internal Medicine[MESH]|Levodopa/therapeutic use[MESH]|Polysomnography[MESH]|Pramipexole[MESH]|Primary Health Care[MESH]|Restless Legs Syndrome/*diagnosis/drug therapy/etiology[MESH]|Risk Factors[MESH]|Treatment Outcome[MESH] |